Clinical Trial Detail

NCT ID NCT04041128
Title PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

ovarian cancer

carcinosarcoma

triple-receptor negative breast cancer

Therapies

Olaparib

Age Groups: adult senior

No variant requirements are available.